Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Therapeutic efficacy of the F8-IL2 immunocytokine in a metastatic mouse model of lung adenocarcinoma.

Wieckowski S, Hemmerle T, Prince SS, Schlienger BD, Hillinger S, Neri D, Zippelius A.

Lung Cancer. 2015 Jan 31. pii: S0169-5002(15)00080-X. doi: 10.1016/j.lungcan.2015.01.019. [Epub ahead of print]

PMID:
25682318
[PubMed - as supplied by publisher]
2.

Cancer immunology - development of novel anti-cancer therapies.

Rothschild SI, Thommen DS, Moersig W, Müller P, Zippelius A.

Swiss Med Wkly. 2015 Feb 4;145:w14066. doi: 10.4414/smw.2015.14066. eCollection 2015.

PMID:
25668078
[PubMed - in process]
Free Article
3.

Phase diagram of selectively cross-linked block copolymers shows chemically microstructured gel.

von der Heydt A, Zippelius A.

J Chem Phys. 2015 Feb 7;142(5):054901. doi: 10.1063/1.4905831.

PMID:
25662662
[PubMed - in process]
4.

Induced PD-L1 Expression Mediates Acquired Resistance to Agonistic Anti-CD40 Treatment.

Zippelius A, Schreiner J, Herzig P, Müller P.

Cancer Immunol Res. 2015 Jan 26. [Epub ahead of print]

PMID:
25623164
[PubMed - as supplied by publisher]
5.

Cancer chemotherapy agents target intratumoral dendritic cells to potentiate antitumor immunity.

Müller P, Martin K, Theurich S, von Bergwelt-Baildon M, Zippelius A.

Oncoimmunology. 2014 Aug 3;3(8):e954460. eCollection 2014.

PMID:
25610745
[PubMed]
6.

Vemurafenib-induced radiation recall dermatitis: case report and review of the literature.

Conen K, Mosna-Firlejczyk K, Rochlitz C, Wicki A, Itin P, Arnold AW, Gross M, Zimmermann F, Zippelius A.

Dermatology. 2015;230(1):1-4. doi: 10.1159/000365918. Epub 2014 Nov 29.

PMID:
25472806
[PubMed - in process]
7.

Jamming of frictional particles: a nonequilibrium first-order phase transition.

Grob M, Heussinger C, Zippelius A.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 May;89(5):050201. Epub 2014 May 27.

PMID:
25353726
[PubMed - in process]
8.

Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer.

Sebastian M, Papachristofilou A, Weiss C, Früh M, Cathomas R, Hilbe W, Wehler T, Rippin G, Koch SD, Scheel B, Fotin-Mleczek M, Heidenreich R, Kallen KJ, Gnad-Vogt U, Zippelius A.

BMC Cancer. 2014 Oct 6;14:748. doi: 10.1186/1471-2407-14-748.

PMID:
25288198
[PubMed - in process]
Free PMC Article
9.

Strong dynamical heterogeneity and universal scaling in driven granular fluids.

Avila KE, Castillo HE, Fiege A, Vollmayr-Lee K, Zippelius A.

Phys Rev Lett. 2014 Jul 11;113(2):025701. Epub 2014 Jul 10.

PMID:
25062209
[PubMed - in process]
10.

Cetuximab in metastatic squamous cell cancer of the skin: a Swiss case series.

Conen KL, Fischer N, Hofbauer GF, Shafaeddin-Schreve B, Winterhalder R, Rochlitz C, Zippelius A.

Dermatology. 2014;229(2):97-101. doi: 10.1159/000362384. Epub 2014 Jun 7.

PMID:
24923455
[PubMed - in process]
11.

Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cells.

Müller P, Martin K, Theurich S, Schreiner J, Savic S, Terszowski G, Lardinois D, Heinzelmann-Schwarz VA, Schlaak M, Kvasnicka HM, Spagnoli G, Dirnhofer S, Speiser DE, von Bergwelt-Baildon M, Zippelius A.

Cancer Immunol Res. 2014 Aug;2(8):741-55. doi: 10.1158/2326-6066.CIR-13-0198. Epub 2014 Apr 21.

PMID:
24916470
[PubMed - in process]
12.

The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity.

Martin K, Müller P, Schreiner J, Prince SS, Lardinois D, Heinzelmann-Schwarz VA, Thommen DS, Zippelius A.

Cancer Immunol Immunother. 2014 Sep;63(9):925-38. doi: 10.1007/s00262-014-1565-4. Epub 2014 Jun 7.

PMID:
24906866
[PubMed - indexed for MEDLINE]
13.

Active microrheology of driven granular particles.

Wang T, Grob M, Zippelius A, Sperl M.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Apr;89(4):042209. Epub 2014 Apr 28.

PMID:
24827243
[PubMed - in process]
14.

Temperature-dependent defect dynamics in the network glass SiO2.

Vollmayr-Lee K, Zippelius A.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Nov;88(5):052145. Epub 2013 Nov 27.

PMID:
24329252
[PubMed]
15.

Antibody-based immunotherapy for ovarian cancer: where are we at?

Tse BW, Collins A, Oehler MK, Zippelius A, Heinzelmann-Schwarz VA.

Ann Oncol. 2014 Feb;25(2):322-31. doi: 10.1093/annonc/mdt405. Epub 2013 Nov 26.

PMID:
24285017
[PubMed - in process]
Free Article
16.

Bundling in brushes of directed and semiflexible polymers.

Benetatos P, Terentjev EM, Zippelius A.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Oct;88(4):042601. Epub 2013 Oct 4.

PMID:
24229200
[PubMed - indexed for MEDLINE]
17.

Elasticity of cross-linked semiflexible biopolymers under tension.

von der Heydt A, Wilkin D, Benetatos P, Zippelius A.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Sep;88(3):032701. Epub 2013 Sep 3.

PMID:
24125288
[PubMed - indexed for MEDLINE]
18.

Anomalous velocity distributions in active Brownian suspensions.

Fiege A, Vollmayr-Lee B, Zippelius A.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Aug;88(2):022138. Epub 2013 Aug 21.

PMID:
24032806
[PubMed]
19.

[Melanoma- finally good news].

Wicki A, Arnold AW, Itin PH, Zippelius A.

Praxis (Bern 1994). 2013 May 22;102(11):667-70. doi: 10.1024/1661-8157/a001293. Review. German.

PMID:
23692905
[PubMed - indexed for MEDLINE]
20.

Glass transition in driven granular fluids: a mode-coupling approach.

Kranz WT, Sperl M, Zippelius A.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Feb;87(2):022207. Epub 2013 Feb 22.

PMID:
23496505
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk